MedPath

PIRAMAL CRITICAL CARE PTY. LTD.

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

TGA:5

Drug Approvals

PIRAMAL DESFLURANE desflurane 1 mL/mL inhalation bottle (314700)

Product Name
PIRAMAL DESFLURANE desflurane 1 mL/mL inhalation bottle
Approval Date
Jan 21, 2020
TGA

RAPIFEN alfentanil 1mg/2mL (as hydrochloride) injection, ampoule (50506)

Product Name
RAPIFEN alfentanil 1mg/2mL (as hydrochloride) injection
Approval Date
Oct 14, 1994
TGA

RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection, ampoule (50508)

Product Name
RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection
Approval Date
Oct 14, 1994
TGA

SUBLIMAZE Fentanyl 100microgram/2mL (as citrate) injection ampoule (48263)

Product Name
SUBLIMAZE fentanyl 100 microgram/2mL (as citrate) injection ampoule
Approval Date
Mar 7, 1994
TGA

SUBLIMAZE fentanyl 500 microgram/10mL (as citrate) injection ampoule (48264)

Product Name
SUBLIMAZE fentanyl 500 microgram/10mL (as citrate) injection ampoule
Approval Date
Mar 7, 1994
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.